Jiangsu Jibeier Pharmaceutical Co Ltd Capital Reinvestment Ratio
Jiangsu Jibeier Pharmaceutical Co Ltd capital reinvestment ratio. Jiangsu Jibeier Pharmaceutical Co Ltd (688566) has a Capital Reinvestment Ratio of 2.24x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥11.07 Million) in capital expenditures (CN¥24.80 Million). See Jiangsu Jibeier Pharmaceutical Co Ltd (688566) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Jiangsu Jibeier Pharmaceutical Co Ltd (2016–2025)
Capital reinvestment ratio of Jiangsu Jibeier Pharmaceutical Co Ltd from 2016 to 2025. This chart tracks Jiangsu Jibeier Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 10 annual periods. See 688566 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Jiangsu Jibeier Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2016–2025)
Jiangsu Jibeier Pharmaceutical Co Ltd capital reinvestment ratio by year from 2016 to 2025. For the full cash flow conversion analysis, see Jiangsu Jibeier Pharmaceutical Co Ltd cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.46x | CN¥248.30 Million | CN¥114.60 Million | ▼ -43.1% |
| 2024 | 0.81x | CN¥215.29 Million | CN¥174.53 Million | ▼ -63.8% |
| 2023 | 2.24x | CN¥159.50 Million | CN¥357.37 Million | ▲ +15.4% |
| 2022 | 1.94x | CN¥150.72 Million | CN¥292.70 Million | ▲ +249.0% |
| 2021 | 0.56x | CN¥150.56 Million | CN¥83.79 Million | ▲ +175.8% |
| 2020 | 0.20x | CN¥117.36 Million | CN¥23.68 Million | ▼ -22.9% |
| 2019 | 0.26x | CN¥115.45 Million | CN¥30.22 Million | ▲ +212.9% |
| 2018 | 0.08x | CN¥97.97 Million | CN¥8.19 Million | ▼ -50.3% |
| 2017 | 0.17x | CN¥111.66 Million | CN¥18.78 Million | ▼ -85.8% |
| 2016 | 1.19x | CN¥39.29 Million | CN¥46.69 Million | — |